EUVIMEDEUVIMED entdecken
Crossref

rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease

Doaa M A Elzoghby, Nermine H Mahmoud, Ahmed S Allam, Aya M Abdallah, Amani M AbdElGhani

The Egyptian journal of Immunology · 2025

DOI: 10.55133/eji.320305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2025. Verfasst von Doaa M A Elzoghby und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, Colitis, Ulcerative, Inflammatory Bowel Diseases, Crohn Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) impacts the gastrointestinal tract, resulting in multiple hospitalizations, complications, and diminished quality of life. IBD has two subtypes: Crohn’s Disease (CD) and Ulcerative Colitis (UC). Evidence suggested that immune response dysregulation and genetic susceptibility are the main disease pathogenesis. IBD diagnosis is established by clinical, laboratory, radiological, endoscopic and histological criteria. MiRNA-146 suppresses proinflammatory cytokines and activates T regulatory lymphocytes (Tregs). Serum miRNA-146b-5p targets genes and cytokines responsible for inhibiting autophagy and maintaining cell homeostasis. This study aimed to evaluate the role of miRNA ‐146b‐5p in diagnosis of IBD and response to treatment. The study consisted of sixty 60 participants separated into 3 groups. Blood samples were withdrawn from 20 acute IBD cases before treatment (Group I), 20 Chronic IBD patients on treatment (Group II) and 20 apparently healthy controls (Group III) for assay of miRNA-146b-5p using the Real-Time polymerase chain reaction (PCR), fecal calprotectin and C reactive protein (CRP). The study revealed statistically significant variation between the 3 studied groups according to stool fecal calprotectin, CRP and microRNA-146b-5p (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsColitis, UlcerativeInflammatory Bowel DiseasesCrohn DiseaseHumansAdultMaleFemaleBiomarkersLeukocyte L1 Antigen ComplexMiddle AgedC-Reactive ProteinYoung AdultFeces

Substanzen

MicroRNAsMIRN146 microRNA, humanBiomarkersLeukocyte L1 Antigen ComplexC-Reactive Protein

Autor:innen und Institutionen

  • Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Zitieren

APA

Elzoghby, D. M. A., Mahmoud, N. H., Allam, A. S., Abdallah, A. M., & AbdElGhani, A. M. (2025). rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.320305

Vancouver

Elzoghby DMA, Mahmoud NH, Allam AS, Abdallah AM, AbdElGhani AM. rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease. The Egyptian journal of Immunology. 2025. doi:10.55133/eji.320305

BibTeX
@article{Elzoghby2025,
  author = {Elzoghby, Doaa M A and Mahmoud, Nermine H and Allam, Ahmed S and Abdallah, Aya M and AbdElGhani, Amani M},
  title = {rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease},
  journal = {The Egyptian journal of Immunology},
  year = {2025},
  doi = {10.55133/eji.320305}
}
Kostenlos starten →